Additionally, GPX4 is necessary for tumor recurrence, indicating that eradicating drug-resistant cancer cells by targeting GPX4 to induce cellular ferroptosis is a promising clinical strategy (Rennekamp, 2017). Here, GPX4 is linked to cancer.